In breast cancer models, CNOT2 has been shown to promote proliferation and angiogenesis through VEGF signaling [15], whereas in colorectal cancer cells, CNOT2 depletion activates p53 signaling via MID1IP1, leading to apoptosis [12]. This evidence concerns the gene TP53 and breast cancer.